These six blue chip stocks can provide safe, secure, and reliable dividends with the potential for some upside to help defeat ...

Announcing a new article publication for Cardiovascular Innovations and Applications journal. With distal transradial access (dTRA), the postoperative compression time remains significantly longer ...

The global cardiovascular devices market, valued at US$ 72.83 billion in 2023, is forecasted to grow at a robust CAGR of 7.3%, reaching US$ ...

Boston Scientific Corporation today announced it has entered into a definitive agreement to acquire Bolt Medical, Inc., the developer of an intravascular lithotripsy (IVL) advanced laser-based ...

Boston Scientific initially developed the concept for the Bolt IVL system, which is engineered to fracture calcium using ...

The biomedical and biotech engineering firm will acquire another development company specializing in cardiovascular disease ...

Acquisition to expand cardiovascular portfolio with complementary and differentiated calcium modification platform, furthering company's strategy to address coronary ...

Boston Scientific has agreed to acquire the rest of Bolt Medical, the developer of an intravascular-lithotripsy, or IVL, laser-based platform for the treatment of coronary and peripheral artery ...

This surge is primarily driven by the growing demand for minimally invasive procedures to treat cardiovascular diseases, which are on ...

IVL has gained attention in recent years as a more precise, efficient, and effective treatment for tough arterial calcium.

Here we report a rare and challenging case of an 81-year-old woman with high-risk unstable angina undergoing emergency catheterization which indicated the presence of single-vessel coronary artery ...